Mechanistic insight into Cancer therapy: The anti-cancer drug Campothecin (CPT) suppresses the expression of human telomerase reverse transcriptase via down regulation of its target miRNA, 24/May/2014, 8.56 am

Mechanistic insight into Cancer therapy: The anti-cancer drug Campothecin (CPT) suppresses the expression of human telomerase reverse transcriptase via down regulation of its target miRNA, 24/May/2014, 8.56 am

Mechanistic insight into Cancer therapy: The anti-cancer drug Campothecin (CPT) suppresses the expression of human telomerase reverse transcriptase via down regulation of its target miRNA, 24/May/2014, 8.56 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Mechanistic insight into Cancer therapy: The anti-cancer  drug Campothecin (CPT) suppresses the expression of human telomerase reverse transcriptase via down regulation of its target miRNA, 24/May/2014, 8.56 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing